Jose M. Trevejo is CHIEF MEDICAL OFFICER of Tarsus Pharmaceuticals, Inc.. Currently has a direct ownership of 2,251 shares of TARS, which is worth approximately $106,472. The most recent transaction as insider was on Dec 20, 2023, when has been sold 2,252 shares (Common Stock) at a price of $20.0 per share, resulting in proceeds of $45,040. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.25K
0% 3M change
50.01% 12M change
Total Value Held $106,472

Jose M. Trevejo Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 20 2023
SELL
Open market or private sale
$45,040 $20.0 p/Share
2,252 Reduced 50.01%
2,251 Common Stock
Oct 05 2023
SELL
Open market or private sale
$28,872 $18.0 p/Share
1,604 Reduced 26.26%
4,503 Common Stock
Mar 23 2023
SELL
Open market or private sale
$5,649 $12.15 p/Share
465 Reduced 7.08%
6,107 Common Stock
Mar 22 2023
SELL
Open market or private sale
$6,686 $12.64 p/Share
529 Reduced 7.45%
6,572 Common Stock
Mar 21 2023
SELL
Open market or private sale
$6,689 $12.89 p/Share
519 Reduced 6.81%
7,101 Common Stock
Mar 20 2023
SELL
Open market or private sale
$6,683 $12.61 p/Share
530 Reduced 6.5%
7,620 Common Stock
Mar 17 2023
SELL
Open market or private sale
$6,693 $13.28 p/Share
504 Reduced 5.82%
8,150 Common Stock
Mar 16 2023
SELL
Open market or private sale
$6,701 $13.43 p/Share
499 Reduced 5.45%
8,654 Common Stock
Mar 15 2023
BUY
Exercise of conversion of derivative security
-
7,549 Added 45.2%
9,153 Common Stock
JMT

Jose M. Trevejo

CHIEF MEDICAL OFFICER
Irvine, CA

Track Institutional and Insider Activities on TARS

Follow Tarsus Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TARS shares.

Notify only if

Insider Trading

Get notified when an Tarsus Pharmaceuticals, Inc. insider buys or sells TARS shares.

Notify only if

News

Receive news related to Tarsus Pharmaceuticals, Inc.

Track Activities on TARS